NCT00230854View on ClinicalTrials.gov

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

July 31, 2007

Conditions
Chronic Hepatitis CHepatitis, Viral, Human
Interventions
DRUG

EMZ702

Trial Locations (2)

N6A 5A5

L.H.S.C. University Campus, London

Unknown

Ottawa Hospital, Ottawa

All Listed Sponsors
lead

OPKO Health, Inc.

INDUSTRY

NCT00230854 - Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin | Biotech Hunter | Biotech Hunter